The Trump administration, with Kennedy as its public health executioner, is determined to roll back decades of scientific ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per ...

Officials at the National Institutes of Health (NIH) have reportedly told scientists to scrub all references to mRNA vaccine technology from grant applications, sparking fears that the agency could ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the covid pandemic and has shown promise in addressing a ...

Below is a chart showing INOD's trailing twelve month trading history, with the $70 strike highlighted in orange: And Moderna Inc (Symbol: MRNA) saw options trading volume of 235,039 contracts ...

Tuberculosis remains the number one cause of infectious mortality worldwide A candidate mRNA vaccine that boosts immunity ...

The vaccine is based on mRNA technology, where genetic instructions are used to trigger an immune response in the body, as opposed to using a weakened or deadened version of an infectious agent.

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 3103.07 with a total volume of 1,821.00. In the following chart, we are able to follow the development of ...